Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJ, Verheugt FW, Wallentin L; ARISTOTLE Investigators.
Lopes RD, et al.
Am Heart J. 2010 Mar;159(3):331-9. doi: 10.1016/j.ahj.2009.07.035.
Am Heart J. 2010.
PMID: 20211292
Clinical Trial.